Please ensure Javascript is enabled for purposes of website accessibility

Aurora Cannabis Stock Rises Despite Deep Q2 Loss

By Eric Volkman - Updated Feb 13, 2020 at 1:12PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The marijuana company's bottom line fell into a deep pool of red ink, but investors didn't seem fazed.

Shares of Aurora Cannabis (ACB 7.75%) were up in Thursday afternoon trading following the release of the company's fiscal 2020 second-quarter results.

For the period, which ended Dec. 31, Aurora booked net revenue of just over 56 million Canadian dollars ($42 million), which was 26% lower than its fiscal Q1 result.

Higher expenses (up 23% sequentially), provisions for returns, and that revenue dive negatively affected the bottom line -- the company's net loss plunged to CA$1.3 billion ($980 million), from the previous quarter's thin profit of almost CA$11 million ($8 million).

A woman cultivating cannabis.

Image source: Getty Images

Following developments last week with Aurora, in which it announced the departure of its CEO, plus a round of job cuts and substantial goodwill impairment charges, many expected the quarter's results would be poor. Analysts were modeling around CA$65.5 million ($49.4 million) in revenue, and a net loss of roughly CA$1.0 billion ($754 million).

In terms of operational and volume metrics, in fiscal Q2 Aurora produced 30,691 kilos of product, and sold 9,501. Those figures represented drops of 26% and 24%, respectively. The company's average net selling price for its cannabis, both medical and recreational, fell to CA$5.54 ($4.18) per gram from the Q1 figure of  CA$5.68 ($4.28).

Aurora wrote in its earnings release that it is "bullish on the long-term potential for the global cannabis opportunity."

"However, due to several short-term factors, there is likely to be a slower than previously expected rate of industry growth in the near-term," Aurora added. The company said it's expecting slight or no cannabis revenue growth on a sequential basis in Q3. It did not proffer more detailed guidance.

Investors appeared to be somewhat relieved that Aurora's performance wasn't too much worse than expected. The closely watched marijuana stock was up by slightly more than 1% as of 2 p.m. Thursday.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Aurora Cannabis Stock Quote
Aurora Cannabis
$1.53 (7.75%) $0.11

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/25/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.